The transaction creates a fleet of 120 satellites across two orbits, strenthening provision capabilities for customers around the world ...

The current broadband coverage area requisites and the expected user demand is satisfied by the state of the art satellite industry by using multiple spot beams of high throughput satellites with ...

With the global push toward net-zero carbon emissions, consumer demand and standards for sustainable products are rapidly increasing. Green technology capability has become a key engine for ...

Cheap, uninsured satellites are creating more space junk — and it's starting to rain down on our heads.

AI data foundry provider Centific lands $60M to grow enterprise footprint - SiliconANGLESiliconANGLE Media is a recognized leader in digital media innovation serving innovative audiences and ...

Biologist and host Shane Campbell-Staton joins Morning Joe to discuss the new season of PBS's Emmy-nominated docuseries 'Human Footprint,' which offers a science-driven look at how humans have ...

By Dean Seal Shares of InMed Pharmaceuticals were up 71% after the company unveiled preclinical data supporting the potential of INM-901 as a therapeutic candidate in Alzheimer's disease.

INM-901 significantly reduced levels of NLRP3 and IL-1β, two inflammasome markers increasingly implicated in the pathogenesis of Alzheimer's disease and other neuroinflammatory diseases.